LOXO-305, A Next Generation Reversible BTK Inhibitor, for Overcoming Acquired Resistance to Irreversible BTK Inhibitors

Barbara J. Brandhuber, Eliana B Gómez, Steven G. Smith, Todd Eary, Stacey Spencer, S. Michael Rothenberg, Steven W. Andrews

Clinical Lymphoma Myeloma & Leukemia · 2018 · 62 citations · 0 references

Concepts